AG, arabinogalactan; ASF, asialofetuin; ASGP-R, asialoglycoprotein receptor; BW, body weight; CA, contrast agent; DCE, dynamic contrast enhanced; MEM, minimum essential medium; DTPA, diethylene triamine pentaacetic acid, a linear ligand; DOTA, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, a macrocyclic ligand; DOTAGal, 
asialoglycoprotein receptor (ASGP-R), which is decreased to less than 50 % by the presence of its high affinity ligand asialofetuin (ASF). In vivo biodistribution, gammaimaging and pharmaco-kinetic studies on Wistar rats using the [ conjugates show an high uptake in the receptor-rich organ liver of the compounds containing terminal galactosyl groups, but very little uptake for those with terminal glycosyl groups. Blocking the receptor in vivo reduced liver uptake by 90%, strongly suggesting that the liver uptake of these compounds is mediated by their binding to the asyaloglycoprotein receptor (ASGP-R). This study also demonstrated that the valency increase improves the targeting capability of the glycoconjugates, which is also affected by their topology. However despite the specific liver uptake of the radiolabeled galactosebearing multivalent compounds, the animal MRI assessment of the corresponding Gd 3+ chelates shows liver-to-kidney contrast effects which are not significantly better than those shown by GdDTPA. The maximum concentration/dose ratio attained in the kidneys by the Gd 3+ -based CAs is considerably lower than for GdDTPA, indicating that part of the injected CAs is T 1 contrast-silent, presumably when taken up into the liver. The T 1 shortening effect of the Gd 3+ -labeled Gal-containing compounds is probably strongly diminished upon hepatocyte internalization into an endossomic vesicle via receptormediated endocytosis of the ASGP-R.
Keywords: magnetic resonance imaging; contrast agents; gadolinium; glycoconjugates, liver targeting, asialoglycoprotein receptor, gamma scintigraphy
INTRODUCTION
In humans and animals, oligosacharides are covalently bound to proteins (glycoproteins) and lipids (glycolipids) and control a wide variety of cellular processes.
These functions are mediated by a class of membrane receptor proteins belonging to the general family of lectins. Lectins are monomeric or (homo/hetero)-oligomeric proteins, either soluble or membrane-bound, bearing a single or multiple carbohydrate recognizing domain(s) (CRD) per subunit (1, 2) . The CRDs interact specifically with sugars (glucose, mannose, galactose, etc) with affinity constants (lectin-monomeric sugar) (K d ) in the milimolar range (3) . Assembly of monomeric units produces oligomeric lectins displaying an array of CRDs with a variety of topologies (4) . Often one or both of the interacting sugar/lectin partners are membrane-bound. A membrane-bound lectin (receptor) may recognize a soluble or a membrane-bound oligosaccharide (5) . Both types of interactions are appealing for pharmacologic intervention as long as the intrinsically low monomeric sugar-lectin affinity can be overcome (6) . The use of soluble multivalent glycoconjugate constructs displaying a cluster glycosid effect is mandatory for the targeting of cell/organspecific lectins for drug delivery purposes and for the inhibition of cell-cell or cell-foreign body (bacteria/virus) interactions (7, 8) . The hepatic asialoglycoprotein receptor (ASGP-R)
is an organ-specific lectin, not found anywhere else in the body except on the surface of hepatocytes. This hetero-oligomeric lectin has affinity for terminal β-galactoside and β-Nacetyl-galactosaminyl residues on glycoproteins. Although its precise function in vivo is still unclear, it is involved in selectively removing de-sialylated glycoproteins, with exposed terminal galactose residues, from serum (9) . In addition to asialoglycoproteins, the ASGP-R recognises β-galactoside and N-acetyl-β-galactosaminyl residues appended to a variety of artificial molecular scaffolds (10 -13) .
Annually many people die worldwide of liver cancer following hepatitis B. The functional imaging of liver ASGP-R is of both diagnostic and prognostic value during 5 treatment of liver cancer and other liver conditions (14 -16) . Molecular constructs bearing efficient reporter groups and pendant β-galactoside and/or N-Acetyl-β-galactosaminyl residues can lead to hepatocyte-specific imaging agents for liver (11, 14 -16 Tc]-DTPA-GSA), has been used in SPECT (single photon emission computed tomography) hepatic imaging to assess the ASGP-R function in mice (17) . The hepatocyte-specific nature of the ASGP-R and the fact that it is still expressed (although in reduced numbers) on hepatoma cells makes it possible to detect liver cancer metastases to other organs. The same imaging agent, ([ 99m Tc]-DTPA-GSA), has been demonstrated clinically useful in humans to detect liver cancer metastases to the bones (18) and to assess de dynamics of the ASGP-R internalisation/recycling to the surface of the hepatocytes (19, 20) . A Gd-DTPA conjugate of polylysine (PL) derivatized with galactosyl groups (Gd-DTPA-gal-PL) (21) , as well as a spin-labeled arabinogalactan (22), have also been developed as macromolecular potential contrast agents for liver MRI by targeting the hepatocyte ASGP-R. A variety of particulate systems targeted to the ASGP-R have also been tested in cells and mice as potential contrast agents for liver MRI: monocrystalline iron oxide nanoparticles (MION) conjugated to the bovine plasma protein asialofetuin (ASF), (MION-ASF) (23) , arabinogalactan (AG)-coated ultra-small superparamagnetic iron oxide particles (USPIO), (AG-USPIO) (24 -27) . Both the macromolecular and particle-based ASGP-R-targeted imaging agents described above, include carriers bearing multiple reporter groups and a multivalent display of galactosyl targeting groups. However these agents are inherently polydisperse and ill characterised. Chemically well-defined and characterised multivalent agents can be assembled by an alternative molecular design: the conjugation of dendrimeric clustered carbohydrate bifunctional reagents (monodisperse, well defined and characterised) to a reporter group (28) . The resulting conjugates are of substantially lower molecular weight, higher stability and greater biological safety.
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Previous to our report on the synthesis of dendrimeric multivalent glycoconjugates of metal complexes for molecular imaging (MRI and scintigraphy) (29, 30) 
Radiotracer preparation
In initial experiments, stock solutions of the ligands were prepared in isotonic HEPES Samples were then cooled (4°C) and centrifuged for 15 min, at 4000 rpm and 4°C, to 8 precipitate serum proteins. 100 µL of supernatant was removed for activity counting in a γ well-counter. The sediment was washed twice with 1 mL of ethanol and counted. The activities in the supernatant and in the pellet were compared as (activity in the pellet/ activity in supernatant) * 100.
In vitro cell interaction studies
Hep G2 human hepatoma cell line (ECACC, United Kingdom) was grown in 75 mL bottles with MEM (minimum essential medium) from Sigma, which contains 18 mM CaCl 2 , supplemented with 10% FBS (fetal bovine serum) from Gibco Invitrogen, and non-essential aminoacids, glutamine and penicillin/streptomycin, all from Sigma. The cells were counted and transferred to a 6-hole multiwell plate (0.2 million cells/hole), 2 mL of medium were added to each hole and then the cells were incubated at 37 °C, under 5% CO 2 for the period necessary to obtain cell confluence. This is needed because the human hepatocyte carcinoma line Hep G2 expresses maximum receptor activity only in confluent cultures (33) . The medium was changed every day. In the day of the experiments the medium was removed and the cells were washed twice with 1.5 mL of medium before adding 1.2 mL of medium and they were allowed to adjust for 1 h at 37 °C. Approximately 1 µCi of radiolabeled ligand was added in each well to the medium and the cells were incubated for 30 min, 1 h and 2 h at 37
°C. To three of the holes in each plate an excess of asialofetuin (Sigma) (200 µL of a 0.2 mg/mL solution) (31) was added simultaneously with the radiolabeled ligand in order to evaluate the contribution of non-specific contributions to the cell uptake of the glycoconjugates. At appropriate time periods the experiment was stopped by removal of the medium and washing the cells twice with 750 µL ice-cold phosphate buffered saline. The medium plus PBS was collected to tubes to measure the radioactivity. Finally, the cells were treated with 1 N NaOH (1 mL) and incubated at 37 °C for 10 min, to detach them from the plates, and the radioactivity was measured in a γ-counter. Each experiment was carried out simultaneously in triplicate.
In vivo gamma imaging
A gamma camera-computer system (GE 400 GenieAcq, from General Electric, Milwaukee, USA) was used for acquisition and pre-processing. Data processing and display were performed on a personal computer using homemade software developed for the IDL 5.2 computer tool. A well counter (DPC-Gamma C 12 , LA, USA) with a Compaq
DeskPro compatible computer was used for activity counting in the biodistribution studies. 
Magnetic resonance imaging
The MRI experiments were performed on a Bruker Pharmascan system (Bruker Medical Gmbh, Ettlingen, Germany) using a 7.0-T horizontal-bore superconducting magnet, equipped with a 1 H selective birdcage resonator of 38 mm and a Bruker gradient insert with 90 mm of diameter (maximum intensity 300 mT/m). All the data were acquired using a Hewlett-Packard console running Paravision software (Bruker Medical Gmbh, Ettlingen,
Germany) operating on a Linux platform. All MRI studies were performed in accordance with the Spanish law for animal protection. In vivo experiments were performed on albine Swiss male mice, weighing 19-26 g. One animal was measured by MRI for each compound tested.
Anesthesia was initiated by inhalation in an induction box with O 2 (1 l/min) containing 3 % of isofluorane, and maintained during the experiment employing a mask and 1-2 % of isofluorane in O 2 . The mice were taped down gently into a holder, to minimize breathingrelated motion, and were then placed in a heated probe, which maintained the core body temperature at approx. 37 ºC, monitored by a rectal probe. The physiological state of the animal was monitored by a Biotrig physiological monitor (Bruker Medical Gmbh, Ettlingen, Germany) using the respiratory rate and body temperature. The contrast agents were injected as a bolus of 50 µl via a tail vein catheter at a dose of 0.3 mmol Gd Kg where I is the signal intensity at any given time after CA injection and I 0 is the intensity before injection.
Pharmacokinetics were analyzed by calculating the average enhancements within two different ROIs placed on the liver, kidney medulla, kidney cortex and muscle.
Statistical Analysis
All the data obtained in the biodistribution and cell experiments are expressed as means ± standard deviation (SD). For the cell studies results a two tailed t-test was employed to evaluate the signficance of differences of individual pairs of values, and p < 0.05 was considere significant. -DOTAGal 2 uptake in Hep G2 at 37°C with and without ASGP-R blocking, studied in a MEM medium containing 16 mM CaCl 2 . In these conditions, unblocked cell uptake increases with time, reaching 12.6 % of the added activity after 2 h, but without reaching a plateau within the 2 h of incubation. The in vitro cell uptake of the radioligand activity was reduced in the presence of an excess of the ASGP-R blocker asialofetuin, but much less than expected from ASGP-R mediated specific uptake of the radioligand in these ASGP-R rich cells, especially at short incubation times (31). (Fig. 2) . -labeled DOTA-Gal monoamide, using a RPMI-1640 medium containing 50 µM CaCl 2 , gave a 3.1 ratio of non-blocked/blocked uptake at 30 min (31) . The discrepancy between the two studies at low incubation times could be attributed to the larger concentration of CaCl 2 in the cell medium used in the present study, 13 although the litterature study, which used much lower CaCl 2 concentration also reported that ion baseline uptake was drastically reduced in the absence of Ca 2+ (31) .
RESULTS AND DISCUSSION
In vivo gamma imaging and biodistribution. Fig. 3 indicating that the effect of the increase in valence from two to four does not seem to improve liver uptake after one hour. This might be explained by the high number of ASGP-Rs expressed by each hepatocyte cell (36, 37) and/or some degree of steric crowding of the galactose residues. However, the effect of the valence of synthetic and natural glycoconjugates on the affinity to lectins has been fully demonstrated (7, 8) and thus the expected order of increasing affinity of the glycoconjugate ligands for the ASGP-
15
R is tetra>tri>di>mono (7, 8, 41, 42 The data in Fig. 5a also shows that the three ligands bearing only one sugar moiety (DOTAGal, DOTAGlc and DOTALac) stay longer in the blood stream and have a more dispersed biodistribution pattern than the higher valence analogs. Binding to some plasma component might be responsible for this finding. Thus, in addition to the multivalence effect, subtle structural effects arising from the dendrimeric framework of these ligands, especially the tertiary amine nitrogen, might be responsible for the observed differences of biodistribution between the monovalent and multivalent compounds. -DOTAGal 2 . In animals injected with the blocker, activity uptake in liver was reduced by 90 % (p < 0.001) compared with the blocked animals (31). The injection of the blocking dose also increased the uptake in the kidneys by a factor of three, suggesting that more activity is cleared instead of binding to the ASGP-R. These results strongly suggest that the in vivo uptake of the radiolabeled glycoconjugate is specific to the ASGP-R endocytosis. These in vivo results give a much higher 1 hour nonblocked/blocked uptake ratio of 9 that obtained for the Hep G2 cell line in vitro, even at 2
hours. This could in part result from the high Ca 2+ concentrations in the cell medium used in the later studies and also from the fact that the total number of ASGP-R receptors in the human hepatocyte carcinoma cell line HepG2 is 140,000 +/-65,000 sites per cell (43), significantly lower than the value obtained for isolated rat hepatocytes (36, 37) .
A DOTA bisamide glycoconjugate bearing two galactosyl moieties in a cis position, DO2A(cis)Gal 2 ( Fig. 1 ) was also evaluated. 
CONCLUSIONS
Hepatobiliary CAs, with selective hepatocyte uptake by organic anion carriers and biliary excretion, provide a means of obtaining specific liver MRI enhancement and improved detection and characterization of small hepatic lesions (46) . Several potential CAs for liver MRI have also been developed by targeting the hepatocyte ASGP-R and uptake via its endocytic pathway, such as targeted particulate T 2 relaxation agents (23, 27) and macromolecular T 1 relaxation agents (21, 22 ). This approach is also useful in the detection and characterization of hepatic lesions, as they strongly affect the hepatocyte receptor levels (21) . when the entrapped amount of Gd
3+
-chelate is higher than 1 x 10 10 Gd/cell (51).
The fast kidney uptake of these highly hydrophilic complexes will also limit the extent to which they can be concentrated within the hepatocytes up to a concentration high enough to yield a detectable image contrast (52) 
